Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: A population based registry study

Journal of Urology

Volumn 161, Issue 2, 1999, Pages 524-528

  Brasso, Klaus ^a   Friis, Søren ^b   Juel, Knud ^b   Jørgensen, Torben ^b   Iversen, Peter ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Mortality; Prostatic neoplasms; Survival; Treatment outcomes

Indexed keywords

ADULT; AGED; ARTICLE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; REGISTER; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033074459     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61940-2     Document Type: Article

References (29)

1. Johansson, J. and Andersson, S.: Deferred treatment in localized prostatic cancer. Acta Oncol., 30: 221, 1991.
2. Johansson, J., Adami, H., Andersson, S., Bergström, R., Holmberg, L. and Krusemo, U.: High 10-year survival rate in patients with early untreated prostatic cancer. J.A.M.A., 267: 2191, 1992.
3. Chodak, G., Thisted, R., Gerber, G., Johansson, J., Adolfsson, J., Jones, G., Chisholm, G., Moskovitz, B., Livine, P. and Warner, J.: Results of conservative management of clinically localized prostate cancer. New Engl. J. Med., 330: 242, 1994.
4. Johansson, J., Holmberg, L., Johansson, S., Bergström, R. and Adami, H.: Fifteen-year survival in prostate cancer. J.A.M.A., 277: 467, 1997.
5. Jones, G.: Prospective conservative management of localized prostate cancer. Cancer, 70: 307, 1992.
6. Albertsen, P., Fryback, D., Storer, B., Kolon, T. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. J.A.M.A., 274: 626, 1995.
7. Wasson, J., Cushman, C., Bruskewitz, R., Littenberg, B., Mulley, A. J. and Wennberg, J.: A structured literature review of treatment for localized prostate cancer. Arch. Fam. Med., 2: 487, 1993.
8. Lu-Yao, G. and Yao, S.: Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet, 349: 906, 1997.
9. Whitmore, W. J.: Natural history of low-stage prostatic cancer and the impact of early detection. Urol. Clin. N. Amer., 17: 689, 1990.
10. Aus, G., Hugosson, J. and Norlén, L.: Long-term survival and mortality in prostate cancer treated with noncurative intent. J. Urol., 154: 460, 1995.
11. Hugosson, J., Aus, G., Bergdahl, C. and Bergdahl, S.: Prostate cancer mortality in patients surviving more than 10 years after diagnosis. J. Urol., 154: 2115, 1995.
12. Chodak, G.: What to expect from prostate cancer. J. Urol., 154: 2132, 1995.
13. Abrahamsson, P., Adami, H., Taube, A., KyungMann, K., Zelen, M. and Kulldorff, M.: Long-term survival and mortality in prostate cancer treated with noncurative intent. J. Urol., 155: 296, 1995.
14. Hugosson, J. and Aus, G.: Re: editorial: what to expect from prostate cancer. J. Urol., 155: 1138, 1996.
15. Fournier, G. J.: Re: editorial: what to expect from prostate cancer. J. Urol., 155: 1138, 1996.
16. Storm, H., Manders, T. and Lecker, S.: Cancer-incidence in Denmark 1991. Copenhagen: Danish Cancer Society, 1994.
17. Møller, H., Friis, S. and Kjær, S.: Survival of Danish cancer patients. Male genital organs. APMIS, suppl., 101: 3: 122, 1993.
18. Jonsson, P., Danneskiold-Samsøe, B., Heggestad, T., Iversen, P. and Leisti, S.: Management of early prostatic cancer in the Nordic countries: variations in clinical policies and physicians' attitudes toward radical treatment options. Int. J. Tech. Ass., 11: 66, 1995.
19. Brasso, K., Friis, S., Kjær, S. K, Jørgensen, T. and Iversen, P.: Prostate cancer in Denmark. A 50-year population-based study. Urology, 51: 590, 1998.
20. Dugan, J., Bostwick, D., Myers, R., Quin, J., Bergstralh, E. and Oesterling, J.: The definition and preoperative prediction of clinically insignificant prostate cancer. J.A.M.A., 275: 288, 1996.
21. Flemming, C., Wasson, J., Albertsen, P., Barry, M. and Wennberg, J.: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J.A.M.A., 269: 2650, 1993.
22. Mabeck, C. and Wichmann, B.: Cause of death and death certificates. Assessment of the diagnosis in 373 death certificates. Ugeskr Læger, 142: 257, 1980.
23. Asnæs, S. and Østergaard, K: Reliability of death certificates. An autopsy investigation. Ugeskr Læger, 142: 265, 1980.
24. Lepor, H., Kimball, A. and Walsh, P.: Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J. Urol., 141: 82, 1989.
25. Aus, G., Pileblad, E. and Hugosson, J.: Impact of competing mortality on the cancer related mortality in localized prostate cancer. Urology, 46: 672, 1995.
26. Krongrad, A., Lai, H., Lamm, S. and Lai, S.: Mortality in prostate cancer. J. Urol., 156: 1084, 1996.
27. Adami, H. O., Norlen, B. J., Malker, B. and Meirik, O.: Long-term survival in prostatic carcinoma, with special reference to age as a prognostic factor. Scand. J. Urol. Nephrol., 20: 107, 1986.
28. Dillioglugil, Ö., Miles, B. and Scardino, P.: Current controversies in the management of localized prostate cancer. Eur. Urol., 28: 85, 1995.
29. Walsh, P. and Partin, A.: Treatment of early stage prostate cancer. Radical prostatectomy. In: Important Advances in Oncology 1994. Edited by V. DeVita, S. Hellman and S. Rosenberg. Philadelphia: Lippincott Co., pp. 211-223, 1994.